Treatment of Alzheimer’s disease by combination of acupuncture and Chinese medicine based on pathophysiological mechanism: A review

Author:

Liu Zhao1ORCID,Guan Ruiqian12,Bu Fan1,Pan Limin12

Affiliation:

1. Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China

2. Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang Province, China

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by neurodegeneration, nerve loss, neurofibrillary tangles, and Aβ plaques. In modern medical science, there has been a serious obstacle to the effective treatment of AD. At present, there is no clinically proven and effective western medicine treatment for AD. The reason is that the etiology of AD is not yet fully understood. In 2018, the international community put forward a purely biological definition of AD, but soon this view of biomarkers was widely questioned, because the so-called AD biomarkers are shared with other neurological diseases, the diagnostic accuracy is low, and they face various challenges in the process of clinical diagnosis and treatment. Nowadays, scholars increasingly regard AD as the result of multimechanism and multicenter interaction. Because there is no exact Western medicine treatment for AD, the times call for the comprehensive treatment of AD in traditional Chinese medicine (TCM). AD belongs to the category of “dull disease” in TCM. For thousands of years, TCM has accumulated a lot of relevant treatment experience in the process of diagnosis and treatment. TCM, acupuncture, and the combination of acupuncture and medicine all play an important role in the treatment of AD. Based on the research progress of modern medicine on the pathophysiology of AD, this paper discusses the treatment of this disease with the combination of acupuncture and medicine.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference100 articles.

1. Co-pathologies in Alzheimer’s disease: just multiple pathologies or partners in crime?;Tomé;Brain,2021

2. Amyloid, tau and risk of Alzheimer’s disease: a Mendelian randomization study.;Yeung;Eur J Epidemiol,2021

3. On the design of early-phase Alzheimer’s disease clinical trials with cerebrospinal fluid tau outcomes.;Nuño;Clin Trials,2021

4. 2021 Alzheimer’s disease facts and figures.;Alzheimer’s Dementia,2021

5. Diagnosis of early Alzheimer’s disease: clinical practice in 2021.;Porsteinsson;J Prev Alzheimer’s Dis,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3